CVS - CVS Health's Health Services And Pharmacy Benefit Management Business Show Strength In Q3 But Lowers Annual GAAP EPS Outlook | Benzinga
CVS Health Corp's (NYSE: CVS) Q3 sales increased 10.6% Y/Y to $89.76 billion, beating the consensus of $88.25 billion, driven by growth across all segments.
Adjusted EPS was $2.21, up from $2.17 a year ago and beating the consensus of $2.13.
Adjusted operating income increased 2.5%, primarily driven by an increase in the Health Services segment, partially offset by a decline in the Health Care Benefits segment.
The company's pharmacy and consumer wellness segment saw ...